Menü
A unique in vitro human microbiome platform to assess the impact of your product(s) on the composition and the functions of the microbiome.
The broadest range of pre- and probiotic analytic services.
Identify new probiotic potential of your strain(s) and develop new strains with unmet properties.
Our Platform allows to rapidly assess the effect of compounds (e.g. drugs, supplements, foods, probiotics) on the composition and the function of the human microbiome.
ACARYON GmbH • Biotech Campus Berlin-Buch
Robert-Rössle-Str. 10 • Building D79 • 13125 Berlin (Germany)
One of the most important and recent paradigm shifts in medicine is the recognition of the central role that the gut microbiome plays in human health. However, the implementation of research findings in concrete applications is limited by the lack of specific analysis systems. Mainly, there is a lack of reliable and standardized in vitro platforms allowing to run high throughput analysis on the human microbiome. With the financial support of the EU and the state of Berlin, ACARYON develops a new in vitro human microbiome model that aims mimicking the natural gut conditions, thereby allowing to ensure a stable composition of the human microbiome in the system for more than 48 hours.